Showing results (701-710 of 6,300) with videos related to
Sort By:
Pageof 630
Diabetes, Obesity & Metabolism|April 19, 2012
Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes riskS H Ley, S B Harris, P W Connelly, et al.Diabetes, Obesity & Metabolism|April 5, 2012
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysisC F Deacon, E Mannucci, B AhrénDiabetes, Obesity & Metabolism|May 17, 2011
Why does quick-release bromocriptine decrease cardiac events?D S H BellDiabetes, Obesity & Metabolism|August 9, 2011
Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trialV Koivisto, S Cleall, A E Pontiroli, et al.Diabetes, Obesity & Metabolism|November 5, 2011
The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutideA H BarnettDiabetes, Obesity & Metabolism|November 5, 2011
Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2Q Li, L Chen, Z Yang, et al.Diabetes, Obesity & Metabolism|November 5, 2011
GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetesT Araki, M Hirayama, S Hiroi, et al.Diabetes, Obesity & Metabolism|December 21, 2007
Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy databaseR E Pratley, A Schweizer, J Rosenstock, et al.Diabetes, Obesity & Metabolism|December 21, 2007
The effectiveness of glibenclamide in women with gestational diabetesR I G Holt, P Clarke, E C Parry, et al.Diabetes, Obesity & Metabolism|December 20, 2016
Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory studyDaisuke Yabe, Masahiro Iwasaki, Hitoshi Kuwata, et al.Pageof 630